<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00034606</url>
  </required_header>
  <id_info>
    <org_study_id>5115</org_study_id>
    <secondary_id>H3E-MC-JMEL</secondary_id>
    <nct_id>NCT00034606</nct_id>
  </id_info>
  <brief_title>Comparing 3 Schedules of Alimta Plus Gemzar</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to measure tumor response rates for three schedules of
      Alimta(LY231514) in combination with gemcitabine in patients with locally advanced or
      metastatic non small cell lung cancer who have received no prior chemotherapy regimen.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Carcinoma, Non-Small-Cell Lung</condition>
  <condition>Lung Neoplasms</condition>
  <condition>Neoplasms</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pemetrexed (Alimta) in combination with gemcitabine (Gemzar)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of non-small lung cancer

          -  No prior chemotherapy

          -  Able to care for self

        Exclusion Criteria:

          -  An ongoing infection

          -  Pregnancy or breast feeding

          -  Other serious medical condition

          -  Cancer that has spread to the brain

          -  Inability to take folic acid
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2002</study_first_submitted>
  <study_first_submitted_qc>May 1, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2002</study_first_posted>
  <last_update_submitted>July 18, 2006</last_update_submitted>
  <last_update_submitted_qc>July 18, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2006</last_update_posted>
  <keyword>Lung cancer</keyword>
  <keyword>cancer</keyword>
  <keyword>neoplasm</keyword>
  <keyword>non-small</keyword>
  <keyword>chemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gemcitabine</mesh_term>
    <mesh_term>Pemetrexed</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

